Literature DB >> 11490816

Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.

T Itamoto1, T Asahara, K Katayama, H Nakahara, T Fukuda, M Yano, H Hino, M Nakahara, K Dohi, F Shimamoto.   

Abstract

BACKGROUND/AIMS: The aim of this study was to investigate the clinicopathologic features and biological behaviors related to the gross appearance of intrahepatic cholangiocarcinoma.
METHODOLOGY: Fourteen patients with intrahepatic cholangiocarcinoma who underwent hepatic resection between 1986 and 1998 were divided into four groups according to the gross appearance of the tumor: ID (intraductal growth) type (n = 1), PD (periductal-infiltrating) type (n = 4), MF (mass-forming) type (n = 5), MF-with-PD type (n = 4).
RESULTS: Overall survival at 1, 5, and 10 years was 50.0%, 35.7%, and 35.7%, respectively. All three long-term survivors without recurrence had tumors unassociated with vascular invasion, intrahepatic metastasis, or lymph node metastasis. The MF and MF-with-PD tumors were more frequently associated with vascular invasion and/or lymph node metastasis than the ID or PD type. The Ki-67-positive grade of the cancer cells was clearly higher in the MF and MF-with-PD tumors than in the ID or PD type. All of the cases of MF-with-PD tumors were stage IV-A and had a poor outcome.
CONCLUSIONS: Extended hepatic resection with a sufficient surgical margin yielded good results in intrahepatic cholangiocarcinoma patients without vascular invasion, intrahepatic metastasis, or lymph node metastasis. However, it is necessary to develop a new effective strategy for advanced intrahepatic cholangiocarcinomas, such as the MF-with-PD type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490816

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  [Surgical therapy of intrahepatic cholangiocellular carcinoma].

Authors:  H Lang; G C Sotiropoulos; E Brokalaki; N R Frühauf; J Radü; A Paul; J Wohlschlaeger; H A Baba; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

2.  Guidelines for palliative surgery of cholangiocarcinoma.

Authors:  H Witzigmann; H Lang; H Lauer
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

3.  Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.

Authors:  Chaiwat Tawarungruang; Narong Khuntikeo; Nittaya Chamadol; Vallop Laopaiboon; Jaruwan Thuanman; Kavin Thinkhamrop; Matthew Kelly; Bandit Thinkhamrop
Journal:  BMC Cancer       Date:  2021-05-03       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.